Literature DB >> 33646190

Inter-rater and test-retest reliability of computerized clinical vestibular tools.

Graham D Cochrane1, Jennifer B Christy1, Ethan T Kicker1, Ryan P Kailey1, Brandon K England1.   

Abstract

BACKGROUND: Clinical vestibular technology is rapidly evolving to improve objective assessments of vestibular function. Understanding the reliability and expected score ranges of emerging clinical vestibular tools is important to gauge how these tools should be used as clinical endpoints.
OBJECTIVE: The objective of this study was to evaluate inter-rater and test-retest reliability intraclass correlation coefficients (ICCs) of four vestibular tools and to determine expected ranges of scores through smallest real difference (SRD) measures.
METHODS: Sixty healthy graduate students completed two 1-hour sessions, at most a week apart, consisting of two video head-impulse tests (vHIT), computerized dynamic visual acuity (cDVA) tests, and a smartphone-assisted bucket test (SA-SVV). Thirty students were tested by different testers at each session (inter-rater) and 30 by the same tester (test-retest). ICCs and SRDs were calculated for both conditions.
RESULTS: Most measures fell within the moderate ICC range (0.50-0.75). ICCs were higher for cDVA in the inter-rater subgroup and higher for vHITs in the test-retest subgroup.
CONCLUSIONS: Measures from the four tools evaluated were moderately reliable. There may be a tester effect on reliabilities, specifically vHITs. Further research should repeat these analyses in a patient population and explore methodological differences between vHIT systems.

Entities:  

Keywords:  Clinical tools; cDVA; reliability; subjective visual vertical; vHIT

Year:  2021        PMID: 33646190     DOI: 10.3233/VES-201522

Source DB:  PubMed          Journal:  J Vestib Res        ISSN: 0957-4271            Impact factor:   2.435


  2 in total

1.  Test-retest of the Subjective Visual Vertical Test performed using a mobile application with the smartphone anchored to a turntable.

Authors:  Laura Riera-Tur; Encarnación Antúnez-Estudillo; Juan M Montesinos-González; Antonio J Martín-Mateos; Alfonso M Lechuga-Sancho
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-07-15       Impact factor: 3.236

2.  Low-Dose Intratympanic Gentamicin for Unilateral Ménière's Disease: Accuracy of Early Vestibulo-Ocular Reflex Gain Reduction in Predicting Long-Term Clinical Outcome.

Authors:  Ricardo Wegmann-Vicuña; Raquel Manrique-Huarte; Diego Calavia-Gil; Eduardo Martín-Sanz; Pedro Marques; Nicolas Perez-Fernandez
Journal:  Front Neurol       Date:  2022-03-18       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.